Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 3.42857142857 | 1.75 | 1.87 | 1.64 | 1423730 | 1.70630059 | CS |
4 | 0.1594 | 9.65709438992 | 1.6506 | 1.92 | 1.46 | 1292728 | 1.66500901 | CS |
12 | 0.495 | 37.6425855513 | 1.315 | 1.985 | 1.05 | 3170670 | 1.559358 | CS |
26 | -0.61 | -25.2066115702 | 2.42 | 2.88 | 1.05 | 2524054 | 1.7103745 | CS |
52 | -0.56 | -23.6286919831 | 2.37 | 3.9 | 1.05 | 2392792 | 2.30915978 | CS |
156 | -6.64 | -78.5798816568 | 8.45 | 9.45 | 0.5 | 2539841 | 2.6863807 | CS |
260 | -20.56 | -91.9088064372 | 22.37 | 22.83 | 0.5 | 2052274 | 5.72464671 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales